SecBot SecBot
25-NSE ·Filed Oct 13, 2026

BBLG

Bone Biologics Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed13d 19h ago SEC0001354457-26-000978
Notable filing: 25-NSE
Actionable Insight • Neutral

Monitor Bone Biologics Corp's common stock for any subsequent delisting risk or corporate events, but this filing is a routine warrant removal with no direct read-through to the equity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
BBLG ▲ 0.00% at T+5d
NEUTRAL call 0.00% · α vs SPY +1.15% · entry $0.4300 → $0.4300
Next anchor: T+20d in 14d
Latest observation: T+8 +6.99% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
-3.58%
call -3.58% · α -2.50%
$0.4146
settled 13d ago
T+5d
0.00%
call 0.00% · α +1.15%
$0.4300
settled 7d ago
T+20d
Pending
in 14d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Nasdaq filed a Form 25-NSE to remove Bone Biologics Corp's warrants from listing and registration, citing Section 12d2-2(a)(2) (matured, redeemed, or retired securities). The delisting is effective as of October 12, 2026. This is a routine administrative action for a security that has been redeemed or expired, not a going-concern or operational failure.

Key Facts

  • Nasdaq Stock Market LLC filed Form 25-NSE to delist Bone Biologics Corp's warrants.
  • The delisting is based on 17 CFR 240.12d2-2(a)(2) — matured, redeemed, or retired securities.
  • The filing was accepted by the SEC on October 13, 2026, with an effective date of October 12, 2026.
  • The subject security is identified as 'warrant' (not common stock).
  • The common stock of Bone Biologics Corp (BBLG) remains listed and unaffected by this filing.

Financial Impact

No financial impact — the delisting applies only to the company's warrants, which have matured or been redeemed. The common stock remains listed.

Risk Factors

  • No material risks identified from this filing alone.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-000978
Document: 0001354457-26-000978-index-headers.html0001354457-26-000978
Document: 0001354457-26-000978-index.html0001354457-26-000978
Document: 0001354457-26-000978.txt0001354457-26-000978
6 reports for BBLG
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +65.55%Jul 8, 2026
Filters
Rows
Reports for BBLG — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
25-NSE
NEUTRAL ★ 3/10
$0.4300awaiting T+60—$0.3770 (−12.33%)
Jul 27, 2026
13w ago
EFFECT
BEARISH ★ 8/10
$1.03 $0.4105▲ +59.95%▲ +63.66%$0.3770 (+63.22%)
Jul 20, 2026
14w ago
DEFA14A
NEUTRAL ★ 3/10
$1.11 $0.4300▼ −61.26%▼ −65.23%$0.3770 (−66.04%)
Jul 17, 2026
14w ago
S-3
BEARISH ★ 8/10
$1.12 $0.4300▲ +61.61%▲ +66.45%$0.3770 (+66.34%)
Jul 8, 2026
15w ago
Press Release
BEARISH ★ 7/10
$1.38 $0.4754▲ +65.55%▲ +67.94%$0.3770 (+72.68%)
Jul 2, 2026
16w ago
DEFA14A
NEUTRAL ★ 3/10
$1.42 $0.4912▼ −65.41%▼ −68.42%$0.3770 (−73.45%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 4h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026